H Liu, Q Zhao, L Tan, X Wu, R Huang, Y Zuo, L Chen… - Cancer cell, 2023 - cell.com
Malignant gliomas are largely refractory to immune checkpoint blockade (ICB) therapy. To
explore the underlying immune regulators, we examine the microenvironment in glioma and …